ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis
- 28 March 2002
- Vol. 30 (4) , 582-588
- https://doi.org/10.1016/s8756-3282(02)00682-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Vitamin D Therapy of Osteoporosis: Plain Vitamin D Therapy Versus Active Vitamin D Analog (D-Hormone) TherapyCalcified Tissue International, 1999
- The effect of vitamin D on osteoblasts and osteoclastsCurrent Orthopaedic Practice, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1996
- Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of OsteoporosisNew England Journal of Medicine, 1995
- Effects of 1?-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosisCalcified Tissue International, 1994
- Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues Bearing a Hydroxyalkoxy Group at the 2.BETA.-Position.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993
- Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activityJournal of Bone and Mineral Research, 1991
- Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolismBiochemical and Biophysical Research Communications, 1989
- Evidence That 1,25-Dihydroxyvitamin D3Is the Physiologically Active Metabolite of Vitamin D3*Endocrine Reviews, 1985